Skip to main content

Translate

"The right test, on the right specimen, collected at the right time, is essential for reliable diagnosis" Dr Prashant Goyal

The Sample Matters: The Impact of Anticoagulant Contamination on Laboratory Reports

In laboratory medicine, a test result's accuracy depends not only on the analyser and analytical process but also on the quality of the specimen submitted for testing. Anticoagulant contamination of a serum (or other) sample is an important but often overlooked pre-analytical error that can produce misleading laboratory results, even when the analyser is functioning perfectly and internal quality control is within acceptable limits.

Serum samples are generally collected in plain or serum-separator tubes and are allowed to clot before centrifugation. Contamination may occur when additives from other blood collection tubes inadvertently enter the serum specimen. This can happen because of an incorrect order of draw, inappropriate blood transfer between tubes, collection from an intravenous line, improper phlebotomy technique, or accidental use of the wrong tube.

Anticoagulants are not simply inert substances. They contain chemicals specifically designed to alter coagulation or preserve particular analytes. When these substances contaminate a serum specimen, they can:

  • Add ions to the sample 
  • Chelate essential minerals 
  • Inhibit enzymes 
  • Dilute the specimen 
  • Interfere with analytical reactions 
  • Produce falsely increased or decreased results

Among the different anticoagulants, EDTA contamination is particularly important because it produces a characteristic biochemical pattern. K₂/K₃-EDTA introduces potassium into the specimen and strongly chelates calcium and magnesium. It can also inhibit metal-dependent enzymes such as alkaline phosphatase. Consequently, an EDTA-contaminated serum sample may show markedly increased potassium, decreased calcium and magnesium, and unexpectedly low alkaline phosphatase. The combination of high potassium with very low calcium and low ALP should immediately raise suspicion of EDTA contamination, particularly when the findings do not correlate clinically. 

Citrate contamination can similarly affect serum chemistry, mainly because citrate chelates calcium and the liquid anticoagulant can cause dilution. An unexpectedly low calcium accompanied by reduction in several other analytes may therefore suggest citrate contamination. 

Fluoride/oxalate contamination, usually associated with grey-top tubes, may interfere with glucose-related testing because fluoride inhibits glycolysis. 

Heparin contamination generally produces less characteristic changes in biochemistry parameters, and its effect depends on the type and concentration of heparin and the analytical method being used. Heparin can inhibit PCR and other nucleic-acid amplification reactions. Therefore, heparin contamination can potentially reduce amplification or even cause false-negative/invalid molecular results in susceptible assays. EDTA/heparin contamination in coagulation test samples can produce significantly prolonged or otherwise unreliable coagulation results. Heparin contamination, particularly from samples drawn through heparinised lines, may markedly prolong aPTT and/or thrombin time.

Some immunology and serology assays are validated specifically for serum or plasma, and changing the specimen matrix or introducing another anticoagulant can affect assay performance. Anticoagulant contamination may therefore produce method-dependent interference or results that are not directly comparable with the laboratory's validated reference interval. This is particularly relevant for immunoassays where matrix effects can influence antibody–antigen reactions.

When an unexpected biochemical pattern is observed, the laboratory should consider specimen integrity before attributing the abnormality to disease. Review of previous results, specimen appearance, hemolysis/lipemia indices, tube type, collection procedure and related analytes can be helpful. If contamination is suspected, retesting the same specimen does not correct the problem; an appropriately collected fresh specimen should generally be requested.

Key message: Proper patient identification, correct tube selection, adherence to the order of draw, appropriate venipuncture technique and staff awareness are essential to prevent anticoagulant carryover.

Ultimately, a reliable laboratory report begins with a reliable specimen. The best analyser and the best quality-control program cannot compensate for a pre-analytically compromised sample.


Dr Prashant Goyal 


Labels:

Comments

Post a Comment

Popular posts from this blog

One Disease, Many Tests: Why Different Tuberculosis (TB) Tests Give Different Results?

Tuberculosis (TB) remains one of the most common infectious diseases worldwide. It is caused by the bacterium Mycobacterium tuberculosis . It most commonly affects the lungs (pulmonary TB), but it can also involve other organs (extra-pulmonary TB), such as the brain, lymph nodes, bones, kidneys, intestines, uterus, and other organs. Although several laboratory and radiological tests are available today, diagnosing TB is not always straightforward. Many patients become confused when one TB test is positive while another is negative. They often wonder, "Which report is correct?" Each TB test looks for a different aspect of the disease. Some detect the bacteria directly, while others detect the body's immune response. Therefore, discrepancies are expected in certain situations. Understanding the strengths and limitations of each test helps prevent unnecessary anxiety and inappropriate treatment. Not every mycobacterium causes tuberculosis. True tuberculosis is caused by memb...
Post a Comment
Read more

From Collection to Analysis: Why Blood Samples Need the Cold Chain

In the field of laboratory medicine, precision is paramount. From sample collection to final analysis, every step must be carefully controlled to ensure that test results are accurate and reliable. One often underestimated but critical aspect of this chain is the maintenance of the cold chain during storage and transportation of blood samples . A lapse at this stage can compromise sample integrity, leading to erroneous results that may adversely affect patient diagnosis and treatment. The cold chain refers to the temperature-controlled supply chain that ensures biological samples like blood, plasma, and serum are kept within specified temperature ranges from the point of collection through storage and transportation until they reach the testing laboratory. Depending on the type of sample and required tests, the temperature may vary. Maintaining these temperatures prevents the degradation of blood components and preserves the biochemical and cellular characteristics essential for accur...
Post a Comment
Read more

The Pitfalls of Routine Health check-ups During Acute Illness: What You Need to Know

Preventive health check-ups , which typically include a series of blood tests, play a crucial role in maintaining overall well-being. These check-ups help identify potential health issues early, allowing for timely intervention. However, while these screenings are essential, the timing of when you undergo them is equally important. Getting routine blood tests during an acute illness—such as the flu, a stomach bug, or even a common cold—can lead to misleading results and unnecessary concerns. Here’s why it’s best to delay preventive health check-ups until after you've fully recovered from an acute illness. Understanding Acute Illness and Its Impact on Blood Tests: An acute illness refers to a sudden onset condition that usually lasts for a short period. Common examples include the flu, fever, a cold, or gastroenteritis (Vomiting, Diarrhoea). Although these illnesses are temporary, they cause significant changes in the body’s physiology as it works to fight off the infection or infla...
Post a Comment
Read more